期刊文献+

基于脉搏波的新型血流参数检测仪的研制 被引量:6

Development of A New Hemodynamic Parameters Detecting Instrument Based on Pulse Wave
下载PDF
导出
摘要 为了解决现有的脉搏血流参数检测仪需要事先测量血压值、操作不方便的缺陷,开发了一种基于PC机的新型脉搏血流参数检测仪,可更方便地实现心血管参数的无损检测.本系统集成了一个由RS232串口控制的无创血压测量模块,可实现血压的自动测量.脉搏波信号通过桡动脉脉搏压力传感器获得,经过信号放大、滤波和A/D转换进入计算机.系统软件通过病人身高、体重、血压值等参数根据双弹性腔模型计算出波形系数、心率等血流参数.对比实验和可重复性实验证明本系统具有良好的准确性和较高的可重复性.可以被开发为临床应用的产品,更适合家庭使用. A new instrument is developed to detect hemodynamic parameters, which needs not measure blood pressure beforehand and therefore more convenient. Integrated with a blood pressure measuring module, this system can measure blood pressure value automatically. The signal of pulse wave can be detected by a pulse pressure sensor, amplified and filtered, and finally transferred into digital signal used in PC by means of an A/ D converter. Making use of double elastic cavities module, the software of this system can work out hemodynamic parameters such as heart rate, coefficient of pulse wave, and so on based on basic information of patient including blood pressure value. Demonstrated by comparison experiment and repeatability experiment, this system possesses high accuracy and good repeatability and thus can be applied to clinic and family health care.
出处 《北京工业大学学报》 CAS CSCD 北大核心 2005年第2期189-193,共5页 Journal of Beijing University of Technology
基金 北京市教委基金资助项目(102(KB)00375).
关键词 脉搏波 血流参数 检测仪 pulse wave hemodynamic parameter detecting instrument
  • 相关文献

参考文献5

二级参考文献25

  • 1白净,吴冬生,张菊鹏.对心衰患者施行体外增强型反搏的仿真研究[J].航天医学与医学工程,1993,6(3):204-209. 被引量:2
  • 2白净,吴冬生.桡动脉脉搏波的仿真模型[J].航天医学与医学工程,1995,8(2):94-98. 被引量:12
  • 3李震,陈小鸥,赵星,杨叔子,肖行贯,蔡用之,朱家麟,章晓东.一种脉搏波处理系统[J].中国医疗器械杂志,1989,13(6):322-326. 被引量:2
  • 4[1]Sever PS,Dahlof B,Poulter NR,et al. Prevention of coronary and stroke events with atorvastatin in hypertension patients who have average or lower-than-average cholesterol concentration,in the Angio-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm(ASCOT-ALL): a multicen-tre randomized controlled trial[J]. Lancet,2003;361:1149~1158
  • 5[2]Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 5963 people with diabetes:a randomised placebo-controlled trial[J]. Lancet,2003;363:2005~2016
  • 6[3]The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcome in high-risk hypertension patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:the Antihypertension and Lipid-Lowering Treatment To Prevent Heart Attack Trial(ALLHAT)[J].JAMA,2002;288:2981~2997
  • 7[4]Frohlich E D.Treating hypertension-what are we to believe? [J].N Engl J Med,2003;348:639~641
  • 8[5]Wing L M H,Reid C M,Ryan P,et al,A comparison of outcome with angiotensin-converting enzyme inhibitors and diuretic for hypertensionin the elderly[J].N Engl J Med,2003;348:583~592
  • 9[6]Chobanian AV,Bakris GL,Black HR,et al.The seventh report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure.The JNC 7 Report[J].JAMA,2003;289:2560~2572
  • 10[7]Guidelines Committee.2003 European society of hypertension-European society of Cardiology guidelines for the management of arterial hypertension[J].J Hypertens,2003;21:1011~1053

共引文献135

同被引文献27

引证文献6

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部